Nicotinamide mononucleotide

1. Nicotinamide mononucleotide increases NAD+ in humans.

   “Short-term IV NAD + or NMN administration has been associated with transient increases in circulating NAD + levels”

   Reviewshort-term IV administrationintravenous

   Narrative review of intravenous NAD⁺ and NAD⁺ precursors in wellness and translational medicine · Frontiers in aging · 10 Sep 2026

NAD+ →